Ovarian Epithelial Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Epithelial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Agnostic Therapy in Rare Solid Tumors [Phase 2]
A Phase 2 trial of an agnostic therapy for multiple rare solid tumors is currently recruiting. The study lists a broad set of tumor types ac…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers [Phase 1]
Phase 1 trial to evaluate the safety and preliminary effectiveness of 27T51, a MUC16-targeting immune cell therapy, in adults with recurrent…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC [Phase 2]
Phase 2 clinical trial evaluating preliminary efficacy of SKB264 and the effect of clarithromycin on SKB264 pharmacokinetics in ovarian epit…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Massachusetts General Hospital is sponsoring a study to develop a uterine lavage test for detecting ovarian cancer, and the trial is current…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of NX-1607 in Adults With Advanced Malignancies [Phase 1]
A Phase 1 study evaluating NX-1607 in adults with advanced malignancies is actively recruiting across multiple tumor types, including ovaria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2020-02-28Clinical Trial Update: Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. [Phase 4]
Phase 4 trial evaluating fluciclovine uptake in cervical, endometrial, and ovarian epithelial cancers.
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]
This is an update on a Phase 2 clinical trial evaluating a p53 gene therapy for recurrent ovarian epithelial cancer, fallopian tube cancer, …